Carcinoid syndrome due to a malignant somatostatinoma

4Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Somatostatinoma is one of the rarest tumours of the endocrine pancreas. Cardinal manifestations of a somatostatinoma include gallstones, mild diabetes mellitus, steatorrhoea, diarrhoea and dyspepsia. Like any other pancreatic islet cell carcinoma, a somatostatinoma may also produce several different hormones such as adrenocorticotropic hormone, calcitonin, vasoactive intestinal polypeptide, pancreatic polypeptide, gastrin, insulin, and glucagon. In many cases, the clinical picture is dominated by the effect of these other hormones. We present a patient with somatostatinoma in which an immunocytochemical study of the specimens from pancreas and liver showed a weak positive reaction for gastrin besides a strong positive reaction for somatostatin. Interestingly, this patient also showed the signs of carcinoid syndrome which was successfully treated with octreotide.

Cite

CITATION STYLE

APA

Ozbakir, O., Kelestimur, F., Ozturk, F., Sozuer, E., Unal, A., Patiroglu, T. E., & Guven, K. (1995). Carcinoid syndrome due to a malignant somatostatinoma. Postgraduate Medical Journal, 71(841), 695–698. https://doi.org/10.1136/pgmj.71.841.695

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free